glp 1 drugs for hashimoto's disease Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study Upcoming wave of hormone-based therapies
Description
Surprisingly, a slight improvement in change of peak oxygen consumption (peak VO 2 ) was observed in the albiglutide group compared with placebo (mean 0.9 0.5 ml/kg/min versus 0.6 0.5 ml/kg/min
Weight loss is linked to reduced hepatic steatosis
Zebenholzer, Karin (Department of Neurology, Medical University of Vienna)
Int J Obes (Lond) 2014;38(6):784793
